Diagnostic Yield And Treatment Impact Of Targeted Exome Sequencing In Early-Onset Epilepsy
Michelle K. Demos, Ilaria Guella, C DeGuzman, Marna B. McKenzie, Sarah E. Buerki, Daniel M. Evans, Eric B. Toyota, Cyrus G. Boelman, Linda L. Huh, Anita Datta, Aspasia Michoulas, Kathryn A. Selby, Bruce Björnson, Gabriella Ana Horvath, Elena Lopez‐Rangel, , Matthew James Farrer
This study evaluates the diagnostic yield and treatment impact of targeted whole-exome sequencing in early-onset epilepsy, finding a 34% diagnostic rate with faster diagnosis and cost savings when used early.
Frontiers in Neurology · May 21, 2019Peer-reviewedGenetics